Events - Spark Newswire

1 minute read

Jounce Therapeutics Presents INNATE Phase 1 And SELECT Clinical Trial Data At The European Society Of Medical Oncology Immuno-Oncology Annual Congress

Today, 2:52 AM

- INNATE trial Phase 1 dose escalation data showed JTX-8064 was well-tolerated as a single agent and in combination with pimivalimab (pimi) - - Patient with advanced biliary tract cancer who failed multiple lines

JNCE

1 minute read

GE HealthCare Provides Medium-Term Financial Targets At Investor Day Ahead Of Its Planned Spin-Off As An Independent Company

By Benzinga Newsdesk

Today, 2:52 AM

Strong long-term growth prospects as a global leader in precision care post-spin-off from GE Revenue and margin growth drivers: innovation, business optimization, and organic investment Spin completion expected after

3 minute read

NGM Bio Presents Preliminary Data from Phase 1 Monotherapy Dose Escalation Trial of NGM707 in Patients with Advanced or Metastatic Solid Tumors at 2022 ESMO-IO; Said Early Signals of Anti-tumor Activity Demonstrated Across Multiple Tumor Types

By Charles Gross

Today, 2:52 AM

NGM Biopharmaceuticals, Inc.

NGM

2 minute read

EXCLUSIVE: How Pudgy Penguins, Pixel Vault Plan To Shake Up Web3: ‘Trailblazing As A Unit’

By Anthony Noto

Today, 2:52 AM

How can two Web3 startups keep the momentum going during a bear market? According to Pudgy Penguins CEO Luca Schnetzler, it's less about competing with each other and more about "linking arms and trailblazing as a unit."

ADDYY

3 minute read

EXCLUSIVE: ‘Ape Talk’ At Benzinga’s Future Of Crypto — Why ‘Absurdity’ Of Bored Ape NFTs Makes Sense

By Adam Eckert

Today, 2:52 AM

Bored Ape Yacht Club NFTs soared in popularity last year as celebrities and athletes steadily adopted the artwork and used the NFTs as identifying images across social

ETH